CN114569574A - 一种三消排毒九味胶囊 - Google Patents
一种三消排毒九味胶囊 Download PDFInfo
- Publication number
- CN114569574A CN114569574A CN202210353021.6A CN202210353021A CN114569574A CN 114569574 A CN114569574 A CN 114569574A CN 202210353021 A CN202210353021 A CN 202210353021A CN 114569574 A CN114569574 A CN 114569574A
- Authority
- CN
- China
- Prior art keywords
- sanxiao
- treating
- toxin expelling
- blood
- ingredient capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 40
- 239000004615 ingredient Substances 0.000 title claims abstract description 21
- 239000003053 toxin Substances 0.000 title claims abstract description 19
- 231100000765 toxin Toxicity 0.000 title claims abstract description 19
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 11
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 11
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 11
- 235000012222 talc Nutrition 0.000 claims abstract description 11
- 239000000454 talc Substances 0.000 claims abstract description 11
- 229910052623 talc Inorganic materials 0.000 claims abstract description 11
- 241000207783 Ipomoea Species 0.000 claims abstract description 10
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 8
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 8
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 8
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 8
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims description 13
- 244000241872 Lycium chinense Species 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 5
- 241000218202 Coptis Species 0.000 claims description 3
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 3
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 3
- 241000207929 Scutellaria Species 0.000 claims description 3
- 241000212322 Levisticum officinale Species 0.000 claims description 2
- 239000001645 levisticum officinale Substances 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 19
- 210000004369 blood Anatomy 0.000 abstract description 19
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000007812 deficiency Effects 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 208000019838 Blood disease Diseases 0.000 abstract description 3
- 208000025747 Rheumatic disease Diseases 0.000 abstract description 3
- 208000014951 hematologic disease Diseases 0.000 abstract description 3
- 208000018706 hematopoietic system disease Diseases 0.000 abstract description 3
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 210000004153 islets of langerhan Anatomy 0.000 abstract description 3
- 208000030159 metabolic disease Diseases 0.000 abstract description 3
- 230000000552 rheumatic effect Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 7
- 241000219061 Rheum Species 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000020084 Bone disease Diseases 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 206010020710 Hyperphagia Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 208000022530 polyphagia Diseases 0.000 description 5
- 238000010926 purge Methods 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 208000017667 Chronic Disease Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 206010006895 Cachexia Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000026500 emaciation Diseases 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000018648 unbalanced nutrition Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种三消排毒九味胶囊,所述的三消排毒九味胶囊包含以下重量份原料:大黄3‑5g、黄芩6‑8g、牵牛子3‑9g、滑石10‑15g、薄荷5‑8g、川芎3‑8g、黄连3‑6g、茯苓10‑15g、枸杞子10‑15g。本方以治疗糖尿病为主,以激活胰岛,疏通气血、活血化瘀,气血障碍、代谢不通为宗旨,以治疗、肾脾虚亏、燥热内生、肠胃三焦、以治疗消渴病为宗旨,且同时本方具备疏肝理气,活血化瘀,通经活络的功效,对治疗心血管和风湿骨病起到一定的疗效。
Description
技术领域
本发明涉及一种三消排毒九味胶囊,具体为中药制备技术领域。
背景技术
糖尿病是一组以高血糖为特征的代谢性疾病,是我国发病率高,危害严重的流行病之一。糖尿病,长期存在的高血糖,导致各种组织,特别是眼、肾、心脏、血管、神经的慢性损害、功能障碍,引发各种糖尿病并发症。
造成糖尿病和心脑血管病的主要病因是因为患者体内营养不均衡,体内毒素过多,脾胃虚亏,三焦不合,气血两淤,胰岛功能下降,燥热内生,脏腑内虚,导致血瘀痰浊,久病致淤,久病生痰,久病入络,久病为肾症,虚实相间,糖尿病导致口渴,多食多尿、气血不通等症状,气血淤堵,同时也是造成心脑血管病因之一。
目前,西医对于糖尿病的治疗主要是控制血糖、血脂和血压,改善血液循环和周围神经病变,使用抗生素抗感染治疗,对溃疡创面的换药处理等。均为保守对症疗法,且西医药物治疗效果有限,功能单一,而且使用周期长,往往需要终身用药。化学药物还会对身体产生强烈刺激,毒副作用大,易反弹、安全性差,易耐药、增加患者的经济负担。 随着社会的进步,越来越多的人们把治疗疾病的目光投向于天然的、无毒副作用的中药类安全药物。中医认为糖尿病属中医“脱疽”范畴,主要为气阴两虚、瘀血阻络,气血不能通达四肢所致。因此,为了更好的治疗糖尿病,缓解病痛,开发并研制一种天然中药制备的针对性和时效性强、毒副作用小、安全性好、疗效显著的中药组合药物对糖尿病的恢复来说实为必要。
发明内容
本发明的目的在于提供一种三消排毒九味胶囊,以治疗糖尿病人为主,以激活胰岛疏通气血,活血化瘀,气血障碍,代谢不通为宗旨,以治疗肾脾虚亏,燥热内生,肠胃三焦,以治疗消渴病为宗旨。
为实现上述目的,本发明提供如下技术方案一种三消排毒九味胶囊包含以下重量份原料:大黄3-5g、黄芩6-8g、牵牛子3-9g、滑石10-15g、薄荷5-8g、川芎3-8g、黄连3-6g、茯苓10-15g、枸杞子10-15g。
作为优选,所述的三消排毒九味胶囊包含以下重量份原料:大黄4g、黄芩5g、牵牛子6g、滑石12g、薄荷6g、川芎6g、黄连5g、茯苓12g、枸杞子12g。
一种三消排毒九味胶囊的制备方法为:按照以上重量份原料配比,将大黄、茯苓、黄连、川芎、黄芩、牵牛子、薄荷、滑石、枸杞在粉碎机中粉碎成100-200目粉末,将混合后的粉末封装于预设的胶囊内,每个胶囊装药0.5g,制成成品胶囊即可服用。
本方中:
1)大黄性寒,味苦、治疗糖尿病人中起到活血通经凉血清热泻火、解毒、治肿痛等功效。
2)茯苓性甘淡平,治疗糖尿病人中起到入心肺脾、健脾和胃,渗湿利水、宁心、安神、治疗失眠多梦等功效。
3)黄连性寒味苦,治疗糖尿病人中起到燥湿泻火肝胆热症、心火旺盛、解毒等功效。
4)川芎性辛寒,治疗糖尿病中起到散淤止血,消肿定痛、改善心肌供血和增加血管的弹性、可扩张冠动脉硬化等功效。
5)黄芩性寒味苦,治疗糖尿病中起到清热利湿入肺降血脂、抗动脉、硬化,降压护肝、解毒等功效。
6)牵牛子性寒味苦,治疗糖尿病中起到泻水通便,消痰涤饮,杀虫,促进体内毒素排出、下泻通便退肿等功效。
7)薄荷性寒,治疗糖尿病中起到抗菌消炎,止咳化痰、疏风散热、腹胀恶心,便秘疏肝等功效。
8)滑石性寒,治疗糖尿病人中起到清热渗湿,利窍、暑热、烦渴、生津液、抗菌、消炎杀菌等功效。
9)枸杞性平,含有大量、维生素和矿物质微量元素,治疗糖尿病人中起到提高免疫力及抵抗力、具备防癌抗癌等功效。
与现有技术相比,本发明的有益效果如下:本方以治疗糖尿病为主,以激活胰岛,疏通气血、活血化瘀,气血障碍、代谢不通为宗旨,以治疗、肾脾虚亏、燥热内生、肠胃三焦、以治疗消渴病为宗旨,且同时本方具备疏肝理气,活血化瘀,通经活络的功效,对治疗心血管和风湿骨病起到一定的疗效。
具体实施方式
下面将结合本发明实施例中对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:
一种三消排毒九味胶囊的制备方法为:按照以上重量份原料配比,将大黄3g、黄芩6g、牵牛子3g、滑石10g、薄荷5g、川芎3g、黄连3g、茯苓10g、枸杞子10g在粉碎机中粉碎成100-200目粉末,将混合后的粉末封装于预设的胶囊内,每个胶囊装药0.5g,制成成品胶囊即可服用。
实施例2:
一种三消排毒九味胶囊的制备方法为:按照以上重量份原料配比,将大黄5g、黄芩8g、牵牛子9g、滑石15g、薄荷8g、川芎8g、黄连6g、茯苓15g、枸杞子15g,在粉碎机中粉碎成100-200目粉末,将混合后的粉末封装于预设的胶囊内,每个胶囊装药0.5g,制成成品胶囊即可服用。
实施例3:
一种三消排毒九味胶囊的制备方法为:按照以上重量份原料配比,将大黄4g、黄芩5g、牵牛子6g、滑石12g、薄荷6g、川芎6g、黄连5g、茯苓12g、枸杞子12g,在粉碎机中粉碎成100-200目粉末,将混合后的粉末封装于预设的胶囊内,每个胶囊装药0.5g,制成成品胶囊即可服用。
临床试验:
本三消排毒九味胶囊对于治疗糖尿病的临床验证。
医院确诊糖尿病患者300人,平均年龄50-70岁,平均分成6组, 分为实验组3组,对比例3组,实验组每日早晚饭后分别服用本实施例1~3制备的三消排毒九味胶囊,每次服用2粒。
对比例每天服用双胍类药物,每天两次,一次两片,连续服用30日。
有效或显效的评价标准为:消瘦、高糖口渴、多食多尿,全身乏力症状改善或者症状消失。
无效的评价标准为:消瘦、高糖口渴、多食多尿,全身乏力症状未消失或者改善甚微,得到的结果如下表所示:
组别 | 显效人数 | 有效人数 | 无效人数 | 有效率 |
实施例1 | 36 | 12 | 2 | 96% |
实施例2 | 34 | 13 | 3 | 94% |
实施例3 | 33 | 13 | 4 | 92% |
对比例1 | 24 | 16 | 10 | 80% |
对比例2 | 21 | 17 | 12 | 76% |
对比例3 | 21 | 20 | 9 | 82% |
结论:实施例1~3的效果优于对比例。且本实施例在改善糖尿病人高糖口渴、多食多尿,全身乏力等症状上疗效显著。
本消排毒九味胶囊对于治疗风湿骨病的临床验证。
临床实例,选择冶骨伤专科医院接诊的临床观察风湿骨病患者,共300例,其中300例采用本发明实施例1-3制备的消排毒九味胶囊进行治疗,治疗期间不使用其它药物。实验组每日早晚饭后分别服用本实施例1~3制备的三消排毒九味胶囊,每次服用2粒,1个月为一个疗程。
其中治愈:风湿骨病患者疼痛消失;
有效:风湿骨病患者疼痛减轻或基本消失;
无效:风湿骨病患者病症基本无变化。
具体结果如表1所示
实施例 | 治愈人数 | 有效人数 | 无效人数 | 有效率 |
实施例1 | 62 | 5 | 33 | 70% |
实施例2 | 61 | 7 | 32 | 68% |
实施例3 | 63 | 6 | 31 | 69% |
本消排毒九味胶囊对于治疗风湿骨病具有一定的疗效。
详细案例如下所示:
具体案例1:
王某,男,60岁,得病多年,生活不能自理,医生检查糖尿病,并发症多次治疗,不见好转,脚多处溃烂,经朋友介绍、寻此方口服、一年零九个月左右症状消失、恢复正常、目前已能劳动。
张某、女55岁,得病多年,医生检查糖尿病、症状、消瘦、高糖口渴、多食多尿,全身乏力,口服本九味散一年多点、症状消失。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (3)
1.一种三消排毒九味胶囊,其特征在于:所述的三消排毒九味胶囊包含以下重量份原料:大黄3-5g、黄芩6-8g、牵牛子3-9g、滑石10-15g、薄荷5-8g、川芎3-8g、黄连3-6g、茯苓10-15g、枸杞子10-15g。
2.根据权利要求1所述的一种三消排毒九味胶囊,其特征在于:所述的三消排毒九味胶囊包含以下重量份原料:大黄4g、黄芩5g、牵牛子6g、滑石12g、薄荷6g、川芎6g、黄连5g、茯苓12g、枸杞子12g。
3.一种基于权利要求1所述的三消排毒九味胶囊,其特征在于:具体制备方法为:按照以上重量份原料配比,将大黄、茯苓、黄连、川芎、黄芩、牵牛子、薄荷、滑石、枸杞在粉碎机中粉碎成100-200目粉末,将混合后的粉末封装于预设的胶囊内,每个胶囊装药0.5g,制成成品胶囊即可服用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210353021.6A CN114569574A (zh) | 2022-04-06 | 2022-04-06 | 一种三消排毒九味胶囊 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210353021.6A CN114569574A (zh) | 2022-04-06 | 2022-04-06 | 一种三消排毒九味胶囊 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114569574A true CN114569574A (zh) | 2022-06-03 |
Family
ID=81779407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210353021.6A Pending CN114569574A (zh) | 2022-04-06 | 2022-04-06 | 一种三消排毒九味胶囊 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114569574A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103301278A (zh) * | 2013-04-16 | 2013-09-18 | 武汉珈创生物技术有限公司 | 一种中药制剂及应用 |
-
2022
- 2022-04-06 CN CN202210353021.6A patent/CN114569574A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103301278A (zh) * | 2013-04-16 | 2013-09-18 | 武汉珈创生物技术有限公司 | 一种中药制剂及应用 |
Non-Patent Citations (2)
Title |
---|
安玲等: "神芎丸加味治疗型糖尿病76例", 《中国民间疗法》 * |
李淑君: "神芎丸加味治疗Ⅱ型糖尿病38例", 《中医研究》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103272169B (zh) | 一种红景天复方组合物在治疗糜烂性胃炎中的用途 | |
CN114366790B (zh) | 防治肿瘤治疗后食欲减退和胃肠道反应的中药组合物 | |
CN101530580B (zh) | 一种治疗溃疡性结肠炎的药物 | |
CN102416121B (zh) | 一种药物组合物在制备治疗胃溃疡的药物中的用途 | |
CN105194462A (zh) | 一种治疗甲状腺炎的中药 | |
CN114569574A (zh) | 一种三消排毒九味胶囊 | |
CN107335039A (zh) | 一种治疗虚寒性胃炎、胃溃疡的中药组合物 | |
CN105213758A (zh) | 一种治疗慢性肺炎的中药组合物及其制备方法 | |
CN1220517C (zh) | 一种治疗胃肠疾病的药物 | |
CN102416120B (zh) | 一种药物组合物在制备治疗糜烂性胃炎的药物中的用途 | |
CN102430073B (zh) | 一种治疗消化性溃疡的药物组合物 | |
CN105311602B (zh) | 一种防治小儿哮喘的中药组合物 | |
CN117414351B (zh) | 用于治疗脾肾阳虚便秘的中药贴剂及其制备方法和应用 | |
CN116549591B (zh) | 一种治疗胃痛的中药组合及其应用 | |
CN102416122B (zh) | 一种药物组合物在制备治疗十二指肠溃疡的药物中的用途 | |
CN100423764C (zh) | 一种内服用于治疗肿瘤的中药组合物 | |
CN106860646B (zh) | 一种用于治疗胃十二指肠溃疡的中药组合物及其制备方法 | |
CN105943639A (zh) | 一种辅助治疗慢性硬脑膜下血肿的中药组合物 | |
CN105833228A (zh) | 一种逆转胃癌耐药性的药物制剂及其用途 | |
CN116650610A (zh) | 治疗消渴症的药物组合物 | |
CN1112204C (zh) | 治疗咳嗽的中药散剂及其制造方法 | |
CN118403096A (zh) | 一种用于治疗鼻炎的方剂及制备方法与应用 | |
CN118542904A (zh) | 一种治疗腹胀的外用中药组合物及其应用 | |
CN104435950A (zh) | 一种治疗上消化道出血症的中药止血散及其制备方法 | |
CN113144148A (zh) | 一种内服加外用治疗肝郁痰湿瘀滞型乳腺增生的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220603 |